中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [3]
海洋研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2016 [1]
2013 [1]
2009 [1]
2006 [1]
学科主题
Oncology [1]
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Structural modification of luteolin from Flos Chrysanthemi leads to increased tumor cell growth inhibitory activity
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 15, 页码: 3464-3467
作者:
Yang, Chao
;
Chen, Hui
;
Lu, Shihai
;
Zhang, Meng
;
Tian, Wei
  |  
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/01/08
Luteolin
Flos Chrysanthemi
Structural modification
Bcl-2 protein
Anti-tumor
Stability of the recombinant anti-erbB2 scFv-Fc-interleukin-2 fusion protein and its inhibition of HER2-overexpressing tumor cells
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 卷号: 42, 期号: 2, 页码: 507-516
作者:
Du, Yu-Jia
;
Lin, Ze-Min
;
Zhao, Ying-Hua
;
Feng, Xiu-Ping
;
Wang, Chang-Qing
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/01/08
anti-erbB2 scFv-Fc-interleukin-2 fusion protein
antibody-cytokine fusion protein
HER2 overexpression
FVB/neu tumor
immunotherapy
A novel anti-tumor protein extracted from Meretrix meretrix Linnaeus induces cell death by increasing cell permeability and inhibiting tubulin polymerization
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 卷号: 35, 期号: 4, 页码: 805-812
作者:
Ning, Xuanxuan
;
Zhao, Jianmin
;
Zhang, Yuyan
;
Cao, Subing
;
Liu, Ming
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2010/12/22
Meretrix Meretrix Linnaeus
Anti-tumor Protein
Cytotoxicity
Cell Membrane Permeability
Cell Cycle
Tubulin Polymerization
Apoptosis
designsynthesisandantitumorevaluationofanewseriesofnsubstitutedthioureaderivatives
期刊论文
OAI收割
actapharmacologicasinica, 2006, 卷号: 27, 期号: 9, 页码: 1259
作者:
Bing Xiong
;
Xishan Xiong
;
Hong Liu
;
Xiaomin Luo
;
Hualiang Jiang
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/07/01
EPIDERMAL-GROWTH-FACTOR
TYROSINE KINASE INHIBITORS
STRUCTURE-BASED DISCOVERY
FACTOR RECEPTOR EGFR
IRREVERSIBLE INHIBITORS
CHEMICAL INHIBITORS
BINDING-SITE
PROTEIN
DOMAIN
DOCKING
N-substituted-thiourea derivatives
anti-tumor
SPAC1
tyrosine kinase inhibitor
virtual screening